Skip to main content
Clinical Trials/IRCT201102175855N1
IRCT201102175855N1CompletedPhase 1

A study on nutritional status of riboflavin and the effect of riboflavin supplementation on disability and quality of life scores in patients with multiple sclerosis

Ahvaz Jondishapour University of Medical Sciences0 sites30 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 1
Status
Completed
Sponsor
Enrollment
30

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to 50 years (—)
Sex
All

Inclusion Criteria

  • 1. Tha approvment of MS disease by MS committee, 2. the age between 18-50 years old, 3. the patient should not decide to change or start disease regulation or symptomatic treatments, 4. using brrietric trice for females in productivity age. exclusion criteria: 1. gestation, 2. intake other vitmins contemporary with riboflavin, 3. contributing in another trials contemporary, 4. the ages under 18 and upper 50 years old.

Exclusion Criteria

  • Not provided

Investigators

Sponsor
Ahvaz Jondishapour University of Medical Sciences

Similar Trials